anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
MindMed · pitchdeck

MindMed | Investor Presentation Deck | 42 slides

42 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

MindMed | Investor Presentation Deck | 42 slides

MindMed · 2024-12
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 25 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides · 2 hits 100% 1/1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits Traction 21 slides 100% 21/21 slides 100% 21/21 slides · 92 hits
— 0/21 slides
19% 4/21 slides 57.1% 12/21 slides 100% 21/21 slides 100% 21/21 slides Roadmap 2 slides 100% 2/2 slides 100% 2/2 slides · 7 hits
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides

Slide inventory

42
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a hub-and-spoke diagram to centralize the company brand around five key strategic pillars.summarize
Open slide detailLoop · Golden Circle
04
The slide combines team headshots with a list of pharmaceutical products they have worked on and a list of previous company affiliations.other
Open slide detailLoop · Golden Circle
05
The chart uses a Gantt-style visualization to represent clinical trial progress.plan_implementation
Open slide detailBeat · RoadmapLoop · Golden Circle
06
The slide uses a horizontal timeline format to track clinical trial milestones.plan_implementation
Open slide detailBeat · RoadmapLoop · Golden Circle
07
transition
Open slide detailLoop · Golden Circle
08
show_traction
Open slide detailLoop · Golden Circle
09
The slide uses a 3x2 matrix structure to contrast clinical efficacy, market opportunity, and current treatment limitations.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
10
Uses a process-flow diagram to illustrate biological mechanism.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
11
Shows specific trial names (Voyage, Panorama, Emerge), sample sizes, randomization, and study phases.plan_implementation
Open slide detailLoop · Golden Circle
12
The slide uses a structured list format to map specific clinical challenges to mitigation strategies.present_framework
Open slide detailLoop · Golden Circle
13
The slide uses a timeline framework to illustrate the stacking of IP protections over time.present_solution
Open slide detailLoop · Golden Circle
14
front_matter
Open slide detailLoop · Golden Circle
15
The slide outlines the clinical development strategy for a drug candidate, emphasizing continuity from Phase 2b to Phase 3.plan_implementation
Open slide detailLoop · Golden Circle
16
The slide uses a bar chart to compare effect sizes (Cohen's d) across four treatment categories.compare_peers
Open slide detailBeat · TractionLoop · Golden Circle
17
The slide uses a list-based framework to map clinical outcomes to target product profile attributes.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
18
The slide outlines two distinct study protocols with specific sample sizes and dosing regimens, including a primary endpoint at week 12.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
19
Includes study timeline, randomization, entry criteria, and endpoints.present_framework
Open slide detailBeat · TractionLoop · Golden Circle
20
Shows a process flow between follow-up observation and potential treatment based on clinical criteria.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
21
Includes logos for Voyage and Panorama studies; references statistical power assumptions in footnotes.analyze_data
Open slide detailBeat · TractionLoop · Golden Circle
22
front_matter
Open slide detailBeat · TractionLoop · Golden Circle
23
The slide uses a table to establish scientific credibility for the company's therapeutic focus.cite_precedent
Open slide detailBeat · TractionLoop · Golden Circle
24
The chart displays LS Mean Change from baseline across multiple dose groups (25, 50, 100, 200 ug) versus placebo.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
25
The slide outlines a clinical trial protocol with a primary endpoint at week 6 and a 40-week extension phase.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
26
Includes study timeline, randomization details, entry criteria, and secondary endpoints.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
27
The slide features the MindMed logo and the specific drug candidate and trial phase.front_matter
Open slide detailBeat · TractionLoop · Golden Circle
28
The slide emphasizes regulatory alignment and standard clinical trial methodology.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
29
Includes study arms, dosing, follow-up timeline, entry criteria, and secondary endpoints.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
30
Uses a comparison table to define what is and is not part of the patient journey.present_framework
Open slide detailBeat · TractionLoop · Golden Circle
31
The slide uses a CONSORT-style flow diagram to track patient retention.analyze_data
Open slide detailBeat · TractionLoop · Golden Circle
32
The table displays mean age, sex distribution, race, and baseline HAM-A and CGI-S scores for n=194 participants.analyze_data
Open slide detailBeat · TractionLoop · Golden Circle
33
The chart highlights the efficacy of the 100ug dose group specifically in the callout box.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
34
Data compares Placebo, 25ug, 50ug, 100ug, and 200ug doses.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
35
MCP-Mod is a statistical methodology for dose-response modeling.analyze_data
Open slide detailBeat · TractionLoop · Golden Circle
36
The chart shows a clear separation between placebo and treatment groups across time points.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
37
The slide uses a structured list format to present safety outcomes.show_traction
Open slide detailLoop · Golden Circle
38
The table highlights that while adverse events occur, they are largely concentrated on the dosing day, suggesting a favorable tolerability profile.analyze_data
Open slide detailLoop · Golden Circle
39
transition
Open slide detailLoop · Golden Circle
40
The slide uses a combination of a cellular-level mechanism diagram and a brain-region-level diagram to explain the drug's effect.present_solution
Open slide detailLoop · Golden Circle
41
The slide uses a bar chart to demonstrate efficacy in an animal model and an icon grid to summarize clinical benefits.present_solution
Open slide detailLoop · Golden Circle
42
This slide serves as a divider or cover page within the deck.front_matter
Open slide detailLoop · Golden Circle